{"schema_version":"1","generated_at":"2026-11-02T09:13:11.070Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mark-zalla","json_url":"https://www.findmykol.com/kol/mark-zalla/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mark-zalla","name":"Mark Zalla","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"city":"Florence","state":"KY","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1356460018","openalex":"A5010905613"},"summary":"Mark Zalla is a Dermatology physician. OpenAlex indexes 25 publications with 1,617 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":25,"cited_by_count":1617,"h_index":14,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":18,"program_years":{"first":2021,"last":null},"rows_total":25,"shown":3,"withheld":22,"rows":[{"payer":"Reprise Biomedical, Inc.","program_year":2025,"amount_usd":19.11,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356460018"},{"payer":"ABBVIE INC.","program_year":2024,"amount_usd":38.9,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356460018"},{"payer":"MIMEDX Group, Inc.","program_year":2024,"amount_usd":34.8,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356460018"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356460018","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":68.6,"classes_total":1,"classes":[{"class":"Nucleoside Metabolic Inhibitor","setting":"prescribed","share_pct":68.6,"drugs":[{"name":"Fluorouracil","share_pct":100}],"max_beneficiaries":19}]},{"area":"Dermatology","share_pct":31.4,"classes_total":1,"classes":[{"class":"Antivirals","setting":"prescribed","share_pct":31.4,"drugs":[{"name":"Imiquimod","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"Mohs Surgery in a Patient With Hailey–Hailey Disease","year":2025,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/dss.0000000000004734","status":"verified"},{"title":"The Use of Human Amnion/Chorion Membrane and Umbilical Cord Grafts for Treatment of a Scalp Wound With Exposed Bone","year":2019,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/dss.0000000000001705","status":"verified"},{"title":"The Use of Human Amnion/Chorion Membrane and Umbilical Cord Grafts for Treatment of a Scalp Wound With Exposed Bone","year":2018,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/00042728-900000000-98566","status":"verified"},{"title":"Reply to “Comment on 2012 appropriate use criteria for Mohs micrographic surgery”","year":2013,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2013.04.014","status":"verified"},{"title":"AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery","year":2012,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2012.06.009","status":"verified"}],"source":"works"},"contact":{"address_1":"7766 EWING BLVD","address_2":"STE 100","city":"Florence","state":"KY","zip":"410427538","phone":"859-283-1033","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1356460018","source":"identity"},"similar":[{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Victoria Werth","slug":"victoria-werth","institution":"Perelman School of Medicine at the University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/victoria-werth","json_url":"https://www.findmykol.com/kol/victoria-werth/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":22,"publications":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2009-12-04","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}